Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Jounce_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
JTX-8064
|
| gptkbp:intendedUse |
immunotherapy
|
| gptkbp:mechanismOfAction |
LILRB2 antagonist
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:LILRB2
|
| gptkbp:bfsParent |
gptkb:Jounce
gptkb:Jounce_Therapeutics |
| gptkbp:bfsLayer |
7
|